Cyclocreatine Suppresses Creatine Metabolism and Impairs Prostate Cancer Progression.
Rachana PatelCatriona A FordLisa RodgersLinda K RushworthJanis FlemingErnest MuiTong ZhangDavid G WatsonVictoria LynchGillian MackayDavid SumptonOwen James SansomJohan Vande VoordeHing Y LeungPublished in: Cancer research (2022)
Enhanced creatine uptake drives prostate cancer progression and confers a metabolic vulnerability to treatment with the creatine analog cyclocreatine.